INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-74 Cr | ₹98 Cr | ₹142 Cr | ₹155 Cr | ₹93 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-74 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
| Mar2021 | ₹93 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-74 Cr | Negative | |
| Mar2024 | ₹98 Cr | -30.78 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | 66.37 | |
| Mar2021 | ₹93 Cr | - | |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,488.9 Cr | 0.7% | -7.7% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,211.0 Cr | 1.6% | 6% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,898.0 Cr | -0.7% | -1.9% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,377.0 Cr | -0.8% | 7.4% | 21.2% | Stock Analytics | |
| CIPLA | ₹122,349.0 Cr | -0.4% | -3.4% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,789.0 Cr | 1.2% | 0.3% | -1.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 0.7% |
-7.7% |
-15.2% |
| SENSEX | 1% |
2.5% |
6.5% |
You may also like the below Video Courses